XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor KPT-335.
Ontology highlight
ABSTRACT: XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor KPT-335.
PROVIDER: PRJNA688482 | ENA |
REPOSITORIES: ENA
ACCESS DATA